Validation of FAPi PET biodistribution by immunohistochemistry in patients with solid cancers: A prospective exploratory study.

Authors

null

Christine Mona

UCLA Ahmanson Translational Theranostics Division, Los Angeles, CA

Christine Mona , Matthias R. Benz , Firas Hikmat , Tristan Grogan , Katharina Lueckerath , Ali A Razmaria , Rana Riahi , Roger Slavik , Mark D Grigis , Giuseppe Carlucci , Kimberly A Kelly , Johannes Czernin , David D Dawson , Jeremie Calais

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Clinical Trial Registration Number

NCT04147494

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3066)

DOI

10.1200/JCO.2021.39.15_suppl.3066

Abstract #

3066

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Javier Soto Sr.

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Assessment of complete pathologic response after neoadjuvant immunotherapy for MSI-H gastrointestinal cancers.

Assessment of complete pathologic response after neoadjuvant immunotherapy for MSI-H gastrointestinal cancers.

First Author: Kruti Bhagirath Vora